Cargando…
Hyperuricemia induces endothelial dysfunction and accelerates atherosclerosis by disturbing the asymmetric dimethylarginine/dimethylarginine dimethylaminotransferase 2 pathway
Hyperuricemia is closely associated with the mobility and mortality of patients with cardiovascular diseases. However, how hyperuricemia accelerates atherosclerosis progression is not well understood. The balance between asymmetric dimethylarginine (ADMA) and dimethylarginine dimethylaminotransferas...
Autores principales: | Lee, Tzong-Shyuan, Lu, Tse-Min, Chen, Chia-Hui, Guo, Bei‐Chia, Hsu, Chiao-Po |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390558/ https://www.ncbi.nlm.nih.gov/pubmed/34438260 http://dx.doi.org/10.1016/j.redox.2021.102108 |
Ejemplares similares
-
Asymmetric Dimethylarginine Limits the Efficacy of Simvastatin Activating Endothelial Nitric Oxide Synthase
por: Hsu, Chiao‐Po, et al.
Publicado: (2016) -
The prognostic value of asymmetric dimethylarginine in patients with cardiac syndrome X
por: Lu, Tse-Min, et al.
Publicado: (2017) -
Asymmetric and Symmetric Dimethylarginine in Adolescents with Hyperuricemia
por: Tenderenda-Banasiuk, Edyta, et al.
Publicado: (2013) -
Toxic Dimethylarginines: Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA)
por: Tain, You-Lin, et al.
Publicado: (2017) -
Asymmetric Dimethylarginine, Endothelial Dysfunction and Renal Disease
por: Aldámiz-Echevarría, Luis, et al.
Publicado: (2012)